Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.


Onkure Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Focused On Discovering And Developing Precision Medicines That Target Biologically Validated Drivers Of Cancers Underserved By Available Therapies. The Company Uses A Structure-Based Drug Design Platform To Develop A Pipeline Of Drug Candidates Aimed At Optimizing Efficacy And Tolerability. The Company Has Multiple Programs Focused On Targeting Oncogenic Pi3kα. Its Flagship Program Is Oki-219. The Company Operates In One Operating Segment: Clinical Research.